Citation: A. Schelling et al., THE LONG-TERM SAFETY AND EFFICACY OF TELMISARTAN COMPARED TO ATENOLOLIN THE TREATMENT OF HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27096-27096
Authors:
VISKOPER RJ
BERNINK PJLM
SCHELLING A
RIBEIRO AB
KANTOLA IM
WILKINS MR
KOBRIN I
Citation: Rj. Viskoper et al., A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING MIBEFRADIL AND AMLODIPINE - 2 LONG-ACTING CALCIUM-ANTAGONISTS WITH SIMILAR EFFICACY BUT DIFFERENT TOLERABILITY PROFILES, Journal of human hypertension, 11(6), 1997, pp. 387-393
Authors:
VANNUETEN L
SCHELLING A
VERTOMMEN C
DUPONT AG
ROBERTSON JIS
Citation: L. Vannueten et al., NEBIVOLOL VS ENALAPRIL IN THE TREATMENT OF ESSENTIAL-HYPERTENSION - ADOUBLE-BLIND RANDOMIZED TRIAL, Journal of human hypertension, 11(12), 1997, pp. 813-819
Authors:
BERNINK PJLM
PRAGER G
SCHELLING A
KOBRIN I
Citation: Pjlm. Bernink et al., ANTIHYPERTENSIVE PROPERTIES OF THE NOVEL CALCIUM-ANTAGONIST MIBEFRADIL (RO-40-5967) - A NEW-GENERATION OF CALCIUM-ANTAGONISTS, Hypertension, 27(3), 1996, pp. 426-432
Authors:
LARSEN J
SYKULSKI R
JENSEN G
DOSSEGGER L
TRIMARCO B
MOCCETTI T
GLOGAR D
SCHELLING A
BOSMA AH
Citation: J. Larsen et al., ADAPTIVE-CHANGES IN THE ACUTE HEMODYNAMIC-EFFECTS OF CILAZAPRIL DURING CHRONIC TREATMENT - COMPARISON WITH LONG-TERM CLINICAL EFFECT, European Journal of Clinical Pharmacology, 50(6), 1996, pp. 433-441